Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey
- PMID: 23943864
- PMCID: PMC3859215
- DOI: 10.1093/jnci/djt169
Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey
Abstract
Background: Shiftwork has been implicated as a risk factor for prostate cancer. Results from prior studies have been mixed but generally support an association between circadian disruption and prostate cancer. Our aim was to investigate the relationship between shiftwork and prostate-specific antigen (PSA) test obtained as part of the National Health and Nutrition Examination Survey (NHANES) study.
Methods: We combined three NHANES surveys (2005-2010) to obtain current work schedule among employed men aged 40 to 65 years with no prior history of cancer (except nonmelanoma skin cancer). Men who reported working regular night shifts or rotating shifts were considered shiftworkers. We obtained the total and percentage free PSA test results for these men and dichotomized total PSA into less than 4.0 ng/mL or 4.0 ng/mL or greater and total PSA of 4.0 ng/mL or greater combined with percentage free PSA less than or equal to 25%. Using multivariable logistic regression models, we compared PSA level among current shiftworkers and nonshiftworkers. All statistical tests were two-sided.
Results: We found a statistically significant, age-adjusted association between current shiftwork and elevated PSA at the 4.0 ng/mL or greater level (odds ratio = 2.48, 95% confidence interval [CI] = 1.08 to 5.70; P = .03). The confounder-adjusted odds ratio was 2.62 (95% CI = 1.16 to 5.95; P = .02). The confounder-adjusted odds ratio for those with total PSA of 4.0 ng/mL or greater and free PSA less than or equal to 25% was 3.13 (95% CI = 1.38 to 7.09; P = .01).
Conclusions: We observed a strong positive association with shiftwork and elevated PSA level. Our data support the notion that sleep or circadian disruption is associated with elevated PSA, indicating that shiftworking men likely have an increased risk of developing prostate cancer.
Comment in
-
Our shifting understanding of factors influencing prostate-specific antigen.J Natl Cancer Inst. 2013 Sep 4;105(17):1264-5. doi: 10.1093/jnci/djt218. Epub 2013 Aug 13. J Natl Cancer Inst. 2013. PMID: 23943863 Free PMC article. No abstract available.
Similar articles
-
Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.Dig Dis Sci. 2017 Feb;62(2):526-533. doi: 10.1007/s10620-016-4401-1. Epub 2016 Dec 19. Dig Dis Sci. 2017. PMID: 27995401
-
Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.J Natl Cancer Inst. 2005 Aug 3;97(15):1132-7. doi: 10.1093/jnci/dji205. J Natl Cancer Inst. 2005. PMID: 16077071
-
Obesity and prostate cancer detection: insights from three national surveys.Am J Med. 2010 Sep;123(9):829-35. doi: 10.1016/j.amjmed.2010.05.011. Am J Med. 2010. PMID: 20800152 Free PMC article.
-
Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians.Ann Intern Med. 1997 Mar 1;126(5):394-406. doi: 10.7326/0003-4819-126-5-199703010-00010. Ann Intern Med. 1997. PMID: 9054286 Review.
-
Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.Ont Health Technol Assess Ser. 2015 May 1;15(11):1-37. eCollection 2015. Ont Health Technol Assess Ser. 2015. PMID: 26366237 Free PMC article. Review.
Cited by
-
Associations of HALP score with serum prostate-specific antigen and mortality in middle-aged and elderly individuals without prostate cancer.Front Oncol. 2024 Sep 20;14:1419310. doi: 10.3389/fonc.2024.1419310. eCollection 2024. Front Oncol. 2024. PMID: 39372874 Free PMC article.
-
Associations between inflammatory burden index, prostate cancer, and mortality among middle-aged and elderly individuals.World J Urol. 2024 Sep 26;42(1):538. doi: 10.1007/s00345-024-05241-5. World J Urol. 2024. PMID: 39325178
-
Circadian rhythms and breast cancer: from molecular level to therapeutic advancements.J Cancer Res Clin Oncol. 2024 Sep 12;150(9):419. doi: 10.1007/s00432-024-05917-w. J Cancer Res Clin Oncol. 2024. PMID: 39266868 Free PMC article. Review.
-
A review for the impacts of circadian disturbance on urological cancers.Sleep Biol Rhythms. 2023 Dec 5;22(2):163-180. doi: 10.1007/s41105-023-00500-1. eCollection 2024 Apr. Sleep Biol Rhythms. 2023. PMID: 38524168 Review.
-
Effectiveness of caffeine and blue-enriched light on cognitive performance and electroencephalography correlates of alertness in a spaceflight robotics simulation.NPJ Microgravity. 2023 Dec 19;9(1):93. doi: 10.1038/s41526-023-00332-w. NPJ Microgravity. 2023. PMID: 38114500 Free PMC article.
References
-
- Czeisler CA, Gooley JJ. Sleep and circadian rhythms in humans. Cold Spring Harb Symp Quant Biol. 2007;72:579–597 - PubMed
-
- Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst. 2001;93(20):1563–1568 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
